Drug Profile
ORG 28611
Alternative Names: SCH 900111Latest Information Update: 20 Oct 2009
Price :
$50
*
At a glance
- Originator Organon
- Class Anaesthetics
- Mechanism of Action Cannabinoid receptor CB1 agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anaesthesia
Most Recent Events
- 20 Oct 2009 Discontinued - Phase-I for Anaesthesia in USA (unspecified route)
- 19 Nov 2007 Organon has been acquired by Schering-Plough